Filing Details
- Accession Number:
- 0000899243-21-021813
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-06-03 16:46:46
- Reporting Period:
- 2021-06-01
- Accepted Time:
- 2021-06-03 16:46:46
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1580063 | Progenity Inc. | PROG | () | DE |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1540542 | Athyrium Opportunities Fund (B) Lp | 325 N. Saint Paul Street, Suite 4900 Dallas TX 75201 | No | No | Yes | No | |
| 1589714 | Athyrium Opportunities Fund (A) Lp | 325 N. Saint Paul Street, Suite 4900 Dallas TX 75201 | No | No | Yes | No | |
| 1815211 | Athyrium Opportunities Associates Iii Gp Llc | 505 Fifth Avenue, Floor 18 New York NY 10017 | No | No | Yes | No | |
| 1815259 | Athyrium Opportunities Associates Co-Invest Llc | 505 Fifth Avenue, Floor 18 New York NY 10017 | No | No | Yes | No | |
| 1815260 | Athyrium Opportunities Iii Co-Invest 1 Lp | 505 Fifth Avenue, Floor 18 New York NY 10017 | No | No | Yes | No | |
| 1815261 | Athyrium Opportunities 2020 Lp | 505 Fifth Avenue, Floor 18 New York NY 10017 | No | No | Yes | No | |
| 1815262 | Athyrium Opportunities Associates Iii Lp | 505 Fifth Avenue, Floor 18 New York NY 10017 | No | No | Yes | No | |
| 1815268 | Athyrium Opportunities Iii Acquisition 2 Lp | 505 Fifth Avenue, Floor 18 New York NY 10017 | No | No | Yes | No | |
| 1815474 | Athyrium Opportunities Associates Lp | 325 N. Saint Paul Street, Suite 4900 Dallas TX 75201 | No | No | Yes | No | |
| 1815479 | Athyrium Opportunities Associates Gp Llc | 325 N. Saint Paul Street, Suite 4900 Dallas TX 75201 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-06-01 | 306,308 | $2.86 | 28,299,741 | No | 4 | P | Indirect | See footnotes |
| Common Stock | Acquisiton | 2021-06-01 | 961,807 | $2.86 | 28,299,741 | No | 4 | P | Indirect | See footnotes |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | See footnotes |
| No | 4 | P | Indirect | See footnotes |
Footnotes
- The 306,308 shares of the Issuer's common stock are directly owned by Athyrium Opportunities III Acquisition LP. Athyrium Opportunities Associates III GP LLC is the general partner of Athyrium Opportunities Associates III LP, which is the general partner of Athyrium Opportunities III Acquisition LP. Athyrium Funds GP Holdings, LLC is the managing member of Athyrium Opportunities Associates III GP LLC. Jeffrey Ferrell is the managing member of Athyrium Funds GP Holdings, LLC and the President of Athyrium Opportunities Associates III GP LLC.
- Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein.
- The 961,807 shares of the Issuer's common stock are held directly by Athyrium Opportunities III Co-Invest 1 LP. Athyrium Opportunities Associates Co-Invest LLC is the general partner of Athyrium Opportunities III Co-Invest 1 LP. Athyrium Funds GP Holdings, LLC is the managing member of Athyrium Opportunities Associates Co-Invest LLC. Jeffrey A. Ferrell is the President of Athyrium Opportunities Associates Co-Invest LLC and the managing member of Athyrium Funds GP Holdings, LLC.
Billionaire Hedge Funds
